News Reduction of share capital Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital Continue Reading Previous FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-1, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary FibrosisNext Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss Related Stories News TSplus Cheers on “Sisters In Rose” as the Adventure Begins in the Trophée Roses des Sables 2025 News DataGrail Privacy Risk Summit: As AI & Privacy Collide, Automation & Guardrails Key to Responsible AI Innovation News Doubleview Gold Corp Announces 320-Meter Eastward Extension at the Hat Polymetallic Deposit, Expanding Mineralized Volume and Remaining Open News U.S. Polo Assn. Wins Gold and Silver Stevie Awards at the 2025 International Business Awards in Lisbon, Portugal News CITIC Telecom CPC Garners CAHK STAR Award 2025 Again News Imagen Network Combines Gemini and xAI Systems to Drive Scalable Creative Intelligence
